Guidance
Update information
July 2019: Because of a risk of abuse and dependence, gabapentin is controlled under the Misuse of Drugs Act 1971 as a class C substance and scheduled under the Misuse of Drugs Regulations 2001 as schedule 3 (as of 1 April 2019). A recommendation has been amended to reflect this change.
Minor changes since publication
October 2021: We added a link to NICE's guideline on babies, children and young people's experience of healthcare in section 1.1.
ISBN: 978-1-4731-2203-1